Post-marketing study design to evaluate the effectiveness of the 9-valent and 4-valent HPV vaccines on serious HPV-related cervical disease in China
The 4-valent (4 v) and 9-valent (9 v) human papillomavirus (HPV) vaccines are approved in China for females aged 9–45 years. However, the real-world impact of 4vHPV or 9vHPV vaccination for the prevention of high-grade cervical disease in Chinese women is lacking. Two post-marketing surveillance stu...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2024-12-01
|
| Serier: | Human Vaccines & Immunotherapeutics |
| Fag: | |
| Online adgang: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2418168 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
